CFS is a debilitating and complex disorder characterized by
profound fatigue. Symptoms affect several body systems, frequently resulting in
broadly reduced participation in daily activities. Definitive diagnosis of CFS
is difficult and a diagnostic test is not available. Currently, diagnosis of
CFS is achieved through the process of eliminating other diseases that have
chronic fatigue as a symptom.

The goal of the partnership is to combine the long-term
expertise at the Charité Clinics for Immune Deficiencies in diagnosing CFS
patients with JPT's high-content peptide microarray approach to discover seromarkers that enable the
development of a diagnostic test system.

"Our previous and ongoing research at the Institute for
Medical Immunology indicates a chronic activation of the immune system for a portion
of our CFS patients," said Prof. Carmen Scheibenbogen, the project team head at
the Charité, in a press release announcing the collaboration. "Preliminary
results using JPT's peptide microarray technology let us hope to find distinct
serological markers that allow better diagnosis and treatment of CFS patients
in the future."

Holger Wenschuh, CEO of JPT, added, "The previous success of
our peptide microarray platform technology in identifying seromarkers in HIV,
autoimmune diseases and cancer has led to this exciting opportunity to use our
arrays to systematically explore other indications with high and unmet
diagnostic and therapeutic need."

The collaboration project is supported in part by Pro FIT, a
funding program of the Investitionsbank Berlin and by the European Union.

JPT Peptide Technologies is a provider of peptide-based
products and services, including custom peptides, peptide arrays and
ready-to-use kits and profiling assays.

The Institute for Medical Immunology is a research institute
of the medical faculty of the Université Libre de Bruxelles. Its facilities
include a biosafety level III unit, where equipment is organized into
technology platforms dedicated to flow cytometry, cell culture, molecular
biology and microsurgery.